BBP vs. VPC
Compare and contrast key facts about Virtus LifeSci Biotech Products ETF (BBP) and Virtus Private Credit Strategy ETF (VPC).
BBP and VPC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. VPC is a passively managed fund by Virtus Investment Partners that tracks the performance of the Indxx Private Credit Index. It was launched on Feb 7, 2019. Both BBP and VPC are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BBP vs. VPC - Performance Comparison
Loading graphics...
BBP vs. VPC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 3.94% | 33.15% | 3.32% | 17.88% | 0.85% | -8.17% | 22.24% | 7.68% |
VPC Virtus Private Credit Strategy ETF | -11.66% | -6.75% | 10.52% | 22.20% | -11.70% | 34.18% | -9.50% | 9.32% |
Returns By Period
In the year-to-date period, BBP achieves a 3.94% return, which is significantly higher than VPC's -11.66% return.
BBP
- 1D
- 5.93%
- 1M
- -2.16%
- YTD
- 3.94%
- 6M
- 18.71%
- 1Y
- 41.70%
- 3Y*
- 19.01%
- 5Y*
- 9.37%
- 10Y*
- 12.76%
VPC
- 1D
- 2.93%
- 1M
- -0.03%
- YTD
- -11.66%
- 6M
- -12.28%
- 1Y
- -16.52%
- 3Y*
- 2.20%
- 5Y*
- 2.19%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBP vs. VPC - Expense Ratio Comparison
BBP has a 0.79% expense ratio, which is lower than VPC's 5.53% expense ratio.
Return for Risk
BBP vs. VPC — Risk / Return Rank
BBP
VPC
BBP vs. VPC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Virtus Private Credit Strategy ETF (VPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBP | VPC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.55 | -1.00 | +2.55 |
Sortino ratioReturn per unit of downside risk | 2.18 | -1.30 | +3.49 |
Omega ratioGain probability vs. loss probability | 1.27 | 0.83 | +0.44 |
Calmar ratioReturn relative to maximum drawdown | 2.69 | -0.74 | +3.43 |
Martin ratioReturn relative to average drawdown | 10.18 | -1.75 | +11.93 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BBP | VPC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.55 | -1.00 | +2.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.36 | 0.16 | +0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.18 | +0.21 |
Correlation
The correlation between BBP and VPC is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BBP vs. VPC - Dividend Comparison
BBP has not paid dividends to shareholders, while VPC's dividend yield for the trailing twelve months is around 17.77%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
VPC Virtus Private Credit Strategy ETF | 17.77% | 14.33% | 11.26% | 11.71% | 10.74% | 6.31% | 10.06% | 8.19% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BBP vs. VPC - Drawdown Comparison
The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum VPC drawdown of -53.45%. Use the drawdown chart below to compare losses from any high point for BBP and VPC.
Loading graphics...
Drawdown Indicators
| BBP | VPC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.32% | -53.45% | +9.13% |
Max Drawdown (1Y)Largest decline over 1 year | -13.38% | -22.76% | +9.38% |
Max Drawdown (5Y)Largest decline over 5 years | -38.28% | -24.86% | -13.42% |
Max Drawdown (10Y)Largest decline over 10 years | -44.32% | — | — |
Current DrawdownCurrent decline from peak | -3.90% | -21.75% | +17.85% |
Average DrawdownAverage peak-to-trough decline | -12.16% | -7.41% | -4.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.72% | 9.59% | -5.87% |
Volatility
BBP vs. VPC - Volatility Comparison
Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 11.21% compared to Virtus Private Credit Strategy ETF (VPC) at 5.51%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than VPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BBP | VPC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 5.51% | +5.70% |
Volatility (6M)Calculated over the trailing 6-month period | 18.03% | 10.48% | +7.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.16% | 16.60% | +10.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.23% | 13.39% | +12.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.51% | 20.68% | +6.83% |